Japan — Net Sales
Edwards Lifesciences Japan — Net Sales increased by 3.5% to $90.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $81.80M to $90.60M. Over 4 years (FY 2021 to FY 2025), Japan — Net Sales shows a downward trend with a -9.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful product penetration and demand growth in Japan, while a decrease may signal competitive pressure or regulatory headwinds.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies wi...
Peer comparison
Comparable to regional revenue reporting for multinational medical device firms with significant exposure to the Asia-Pacific market.
ew_segment_japan_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $130.70M | $126.20M | $143.40M | $140.90M | $145.10M | $130.90M | $142.40M | $104.30M | $109.70M | $107.20M | $115.50M | $112.90M | $93.20M | $85.80M | $47.90M | $81.80M | $95.30M | $90.10M | $87.50M | $90.60M |
| QoQ Change | — | -3.4% | +13.6% | -1.7% | +3.0% | -9.8% | +8.8% | -26.8% | +5.2% | -2.3% | +7.7% | -2.3% | -17.4% | -7.9% | -44.2% | +70.8% | +16.5% | -5.5% | -2.9% | +3.5% |
| YoY Change | — | — | — | — | +11.0% | +3.7% | -0.7% | -26.0% | -24.4% | -18.1% | -18.9% | +8.2% | -15.0% | -20.0% | -58.5% | -27.5% | +2.3% | +5.0% | +82.7% | +10.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's japan — net sales?
- Edwards Lifesciences (EW) reported japan — net sales of $90.60M in Q1 2026.
- How has Edwards Lifesciences's japan — net sales changed year-over-year?
- Edwards Lifesciences's japan — net sales increased by 10.8% year-over-year, from $81.80M to $90.60M.
- What is the long-term trend for Edwards Lifesciences's japan — net sales?
- Over 4 years (2021 to 2025), Edwards Lifesciences's japan — net sales has grown at a -9.5% compound annual growth rate (CAGR), from $528.00M to $354.70M.
- What does japan — net sales mean?
- Total revenue earned from sales in the Japanese market.